Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
-3.24%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.9B
Cap. Flow
% of AUM
-14.85%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,580
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| 1 |
PPL Corp
PPL
|
+$274M |
| 2 |
Boeing
BA
|
+$220M |
| 3 |
Estee Lauder
EL
|
+$219M |
| 4 |
Fidelity National Information Services
FIS
|
+$160M |
| 5 |
Kenvue
KVUE
|
+$151M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$517M |
| 2 |
Union Pacific
UNP
|
+$430M |
| 3 |
Pinnacle West Capital
PNW
|
+$189M |
| 4 |
Wells Fargo
WFC
|
+$189M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.34% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.3B
| $3.38M | ﹤0.01% |
129,874
| – | – |
|
602
Omnicell
OMCL
$1.46B
| $3.38M | ﹤0.01% |
74,973
-2,258
| -3% | -$102K |
|
603
Brinker International
EAT
$6.88B
| $3.37M | ﹤0.01% |
106,660
+3,979
| +4% | +$126K |
|
604
Intellia Therapeutics
NTLA
$1.21B
| $3.35M | ﹤0.01% |
106,150
-1,329
| -1% | -$42K |
|
605
American Water Works
AWK
$27B
| $3.35M | ﹤0.01% |
27,090
+24,119
| +812% | +$2.99M |
|
606
CrowdStrike
CRWD
$107B
| $3.35M | ﹤0.01% |
20,007
-47,962
| -71% | -$8.03M |
|
|
BCPC
607
Balchem Corporation
BCPC
$5.05B
| $3.34M | ﹤0.01% |
26,958
-142
| -0.5% | -$17.6K |
|
608
Morgan Stanley
MS
$246B
| $3.34M | ﹤0.01% |
40,918
-1,286
| -3% | -$105K |
|
609
Factset
FDS
$13.7B
| $3.28M | ﹤0.01% |
7,513
-103
| -1% | -$45K |
|
610
Ameren
AEE
$26.8B
| $3.28M | ﹤0.01% |
43,779
-18,383
| -30% | -$1.38M |
|
611
Arcosa
ACA
$4.72B
| $3.26M | ﹤0.01% |
45,290
+38,223
| +541% | +$2.75M |
|
612
Becton Dickinson
BDX
$54B
| $3.19M | ﹤0.01% |
12,324
-2,109
| -15% | -$545K |
|
613
Akamai
AKAM
$11B
| $3.18M | ﹤0.01% |
29,816
+4,641
| +18% | +$494K |
|
614
West Pharmaceutical
WST
$18.4B
| $3.17M | ﹤0.01% |
8,444
-153
| -2% | -$57.4K |
|
|
INN
615
Summit Hotel Properties
INN
$613M
| $3.16M | ﹤0.01% |
545,142
-109,750
| -17% | -$636K |
|
616
Western Union
WU
$2.73B
| $3.16M | ﹤0.01% |
239,740
-8,174
| -3% | -$108K |
|
617
Dynatrace
DT
$14.4B
| $3.14M | ﹤0.01% |
67,276
+6,753
| +11% | +$315K |
|
618
Public Service Enterprise Group
PEG
$40.8B
| $3.14M | ﹤0.01% |
55,231
-116,609
| -68% | -$6.63M |
|
619
Vanguard FTSE Emerging Markets ETF
VWO
$99B
| $3.12M | ﹤0.01% |
79,487
+2,629
| +3% | +$103K |
|
620
Vanguard Short-Term Bond ETF
BSV
$38.5B
| – | – |
0
| – | -$3.38M |
|
621
Martin Marietta Materials
MLM
$37.2B
| $3.1M | ﹤0.01% |
7,549
-37
| -0.5% | -$15.2K |
|
622
iShares Core S&P Total US Stock Market ETF
ITOT
$76.1B
| $3.1M | ﹤0.01% |
32,865
| – | – |
|
623
Health Catalyst
HCAT
$229M
| $3.09M | ﹤0.01% |
305,186
-9,124
| -3% | -$92.3K |
|
624
Neurocrine Biosciences
NBIX
$14B
| $3.07M | ﹤0.01% |
27,253
+25,393
| +1,365% | +$2.86M |
|
625
eXp World Holdings
EXPI
$1.76B
| $3.05M | ﹤0.01% |
188,030
+186,597
| +13,021% | +$3.03M |
|